Unknown

Dataset Information

0

Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models.


ABSTRACT: Malignant soft tissue tumors, particularly highly malignant leiomyosarcomas, are resistant to chemotherapy and associated with a poor prognosis. T-01, a third-generation genetically modified herpes simplex virus type 1, replicates in tumor cells alone and exerts a cell-killing effect. The current study aimed to investigate the antitumor effect of T-01, which is a novel treatment for leiomyosarcoma. In vitro, six human cell lines and one mouse sarcoma cell line were assessed for T-01 cytotoxicity. In vivo, the efficacy of T-01 was examined in subcutaneously transplanted leiomyosarcoma (SK-LMS-1) cells and subcutaneously or intraperitoneally transplanted mouse sarcoma (CCRF S-180II) cells. Cytokines were assessed using ELISpot assay with splenocytes from the allogeneic models for immunological evaluation. T-01 showed cytotoxicity in all seven cell lines (p < 0.001). In the SK-LMS-1 xenotransplantation model, tumor growth was suppressed by T-01 administration (p = 0.02). In the CCRF S-180II subcutaneous tumor model, bilateral tumor growth was significantly suppressed in the T-01-treated group compared with the control group (p < 0.001). In the peritoneal dissemination model, T-01 treatment caused significant survival prolongation compared with the control (p < 0.01). In conclusion, third-generation genetically modified herpes simplex virus type 1 may be an effective novel therapy against refractory sarcomas.

SUBMITTER: Hatta M 

PROVIDER: S-EPMC9118137 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models.

Hatta Masahiko M   Kaibori Masaki M   Matsushima Hideyuki H   Yoshida Terufumi T   Okumura Tadayoshi T   Hayashi Mikio M   Yoshii Kengo K   Todo Tomoki T   Sekimoto Mitsugu M  

Molecular therapy oncolytics 20220426


Malignant soft tissue tumors, particularly highly malignant leiomyosarcomas, are resistant to chemotherapy and associated with a poor prognosis. T-01, a third-generation genetically modified herpes simplex virus type 1, replicates in tumor cells alone and exerts a cell-killing effect. The current study aimed to investigate the antitumor effect of T-01, which is a novel treatment for leiomyosarcoma. <i>In vitro</i>, six human cell lines and one mouse sarcoma cell line were assessed for T-01 cytot  ...[more]

Similar Datasets

| S-EPMC5834814 | biostudies-literature
| S-EPMC4918275 | biostudies-literature
| S-EPMC9364694 | biostudies-literature
| S-EPMC6349778 | biostudies-literature
| S-EPMC8605086 | biostudies-literature
| S-EPMC7178322 | biostudies-literature
| S-EPMC4810253 | biostudies-literature
| S-EPMC3589172 | biostudies-literature
| S-EPMC8235327 | biostudies-literature
| S-EPMC5067929 | biostudies-literature